Yuting Huang is a Senior Principal Scientist at Pfizer, where they have been leading innovative advancements in biotherapeutic development since 2024. Previously, Yuting served as a Senior Scientist at Seagen, directing analytical development for antibody-drug conjugate programs. Their prior experience includes roles at Pfizer from 2017 to 2021, where they developed HPLC methods and implemented multi-attribute methods for various projects. Yuting earned a Ph.D. in Analytical Chemistry from the University of Nebraska-Lincoln, showcasing a strong academic foundation in the field.
This person is not in any offices